» Articles » PMID: 19922574

Predictors of Smoking Relapse by Duration of Abstinence: Findings from the International Tobacco Control (ITC) Four Country Survey

Overview
Journal Addiction
Specialty Psychiatry
Date 2009 Nov 20
PMID 19922574
Citations 96
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To explore predictors of smoking relapse and how predictors vary according to duration of abstinence.

Design, Setting And Participants: A longitudinal survey of 1296 ex-smokers recruited as part of the International Tobacco Control (ITC) Four Country Survey (Australia, Canada, United Kingdom and United States). Measurements Quitters were interviewed by telephone at varying durations of abstinence (from 1 day to approximately 3 years) and then followed-up approximately 1 year later. Theorized predictors of relapse (i.e. urges to smoke; outcome expectancies of smoking and quitting; and abstinence self-efficacy) and nicotine dependence were measured in the survey.

Findings: Relapse was associated with lower abstinence self-efficacy and a higher frequency of urges to smoke, but only after the first month or so of quitting. Both these measures mediated relationships between perceived benefits of smoking and relapse. Perceived costs of smoking and benefits of quitting were unrelated to relapse.

Conclusions: Challenging perceived benefits of smoking may be an effective way to increase abstinence self-efficacy and reduce frequency of urges to smoke (particularly after the initial weeks of quitting), in order to reduce subsequent relapse risk.

Citing Articles

Repeated participation in hospital smoking cessation services and its effectiveness in smoking cessation: a seven-year observational study in Taiwan.

Yang P, Chien Y, Luh D Arch Public Health. 2024; 82(1):241.

PMID: 39716266 PMC: 11667918. DOI: 10.1186/s13690-024-01452-9.


Efficacy of a conversational chatbot for cigarette smoking cessation: Protocol of the QuitBot full-scale randomized controlled trial.

Bricker J, Sullivan B, Mull K, Lavista-Ferres J, Santiago-Torres M Contemp Clin Trials. 2024; 147:107727.

PMID: 39490766 PMC: 11620904. DOI: 10.1016/j.cct.2024.107727.


AERIFY-1/2: two phase 3, randomised, controlled trials of itepekimab in former smokers with moderate-to-severe COPD.

Rabe K, Martinez F, Bhatt S, Kawayama T, Cosio B, Mroz R ERJ Open Res. 2024; 10(5).

PMID: 39319046 PMC: 11417606. DOI: 10.1183/23120541.00718-2023.


Modeling the population health impact of accurate and inaccurate perceptions of harm from nicotine.

Hannel T, Wei L, Muhammad-Kah R, Largo E, Sarkar M Harm Reduct J. 2024; 21(1):145.

PMID: 39123205 PMC: 11312148. DOI: 10.1186/s12954-024-01059-x.


Smoking patterns by birth cohort in Argentina: an age-period-cohort population-based modeling study.

Salgado M, Mok Y, Jeon J, Jaffri M, Tam J, Holford T Lancet Reg Health Am. 2024; 36:100823.

PMID: 39006127 PMC: 11246057. DOI: 10.1016/j.lana.2024.100823.


References
1.
Hyland A, Borland R, Li Q, Yong H, McNeill A, Fong G . Individual-level predictors of cessation behaviours among participants in the International Tobacco Control (ITC) Four Country Survey. Tob Control. 2006; 15 Suppl 3:iii83-94. PMC: 2593055. DOI: 10.1136/tc.2005.013516. View

2.
Blondal T, Gudmundsson L, Olafsdottir I, Gustavsson G, Westin A . Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up. BMJ. 1999; 318(7179):285-8. PMC: 27708. DOI: 10.1136/bmj.318.7179.285. View

3.
French S, Jeffery R, Pirie P, McBride C . Do weight concerns hinder smoking cessation efforts?. Addict Behav. 1992; 17(3):219-26. DOI: 10.1016/0306-4603(92)90027-s. View

4.
Segan C, Borland R, Greenwood K . Can transtheoretical model measures predict relapse from the action stage of change among ex-smokers who quit after calling a quitline?. Addict Behav. 2005; 31(3):414-28. DOI: 10.1016/j.addbeh.2005.05.023. View

5.
Marlatt G, Curry S, Gordon J . A longitudinal analysis of unaided smoking cessation. J Consult Clin Psychol. 1988; 56(5):715-20. DOI: 10.1037//0022-006x.56.5.715. View